GLP1R and type 2 diabetes mellitus: Tanabe et al. also noted that increased triglyceride levels impaired liraglutide efficacy in type 2 diabetes patients, potentially through a reduction in Glp1r expression (Tanabe et al. 2016), suggesting that the effects can be translated to human physiology.